Quality Policy
The leading position Switzer Life Science enjoys today is mainly been accomplished through its delivery of unsurpassed levels of quality maintained for its pharmaceutical range of products. Switzer Life Science’ quality focus encompasses all areas of its manufacturing operations – from procurement of raw materials, to best possible manufacturing technology, functional operations – from on time delivery of formulations, to promotional help pushing its product to become a market brand – thus ensuring a rapid penetration in the domestic markets nation wide. Vendor assessment and assortment is carried out as per stringent quality, product, manufacturing, service and delivery parameters to ensure the highest quality inputs.
The Quality Assurance Department, managed by qualified personnel, constantly examines quality considerations – performing systematic sampling and testing at every stage from raw materials, through each procedure of intermediate and finished pharmaceutical formulations.
A regular validation of processes, test methods, water and environment, as well as periodic calibration of all instruments, to guarantee product output of consistent top quality formulations. A full fledged Quality Control Laboratory at Switzer Life Science’ manufacturing facility follows Good Laboratory Practices (under cGMP norms) and integrates the most up to date testing equipments in order to perform the stringent quality analytical tests prescribed by different Pharmacopoeias.
A separate Microbiology Laboratory with Class 10000 Cleanliness and a SS horizontal Laminar Air Flow Unit. The full spectrum of microbiological and sterility validation tests are conducted for on-going constant microbiological monitoring of all processes and products, as well as personnel and production areas, to ensure total product purity at our manufacturing facilities.
Apart from following and maintaining an effective Quality Management System, Switzer Life Science periodic self-assessments through a voluntary self audit of its operations, in order to remain competitive in the pharmaceutical formulations industry.